NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









U

U.S. Army Medical Research and Development Command

Maryland

Overview

U.S. Army Medical Research and Development Command is a US Army command that funds and executes medical research, development, and acquisition in areas including military infectious diseases, combat casualty care, operational medicine, and chemical biological defense.

Year Founded

1994

Portfolio Companies

17

Investments

U.S. Army Medical Research and Development Command investments
CompanyDateStageLead
Centivax, Inc.Jul 2025GrantCo-investor
Safi BiotherapeuticsFeb 2025GrantLead
Crimson PhoenixSep 2024GrantCo-investor
CohesysJan 2024GrantCo-investor
Nia TherapeuticsAug 2023GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMaryland
Year Founded1994

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.